TuHURA Biosciences, Inc. HURA Accounts payable and other current liabilities (Note 11)
Accounts payable and other current liabilities (Note 11) at other companies
Other financials
Where this comes from
Reported directly by TuHURA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent.
The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about TuHURA Biosciences, Inc.'s accounts payable and other current liabilities (note 11).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TuHURA Biosciences, Inc.'s accounts payable and other current liabilities (note 11)?
- TuHURA Biosciences, Inc. (HURA) reported accounts payable and other current liabilities (note 11) of $5.86M in Q1 2026.
- How has TuHURA Biosciences, Inc.'s accounts payable and other current liabilities (note 11) changed year-over-year?
- TuHURA Biosciences, Inc.'s accounts payable and other current liabilities (note 11) increased by 26.9% year-over-year, from $4.62M to $5.86M.
- What is the long-term trend for TuHURA Biosciences, Inc.'s accounts payable and other current liabilities (note 11)?
- Over 3 years (2022 to 2025), TuHURA Biosciences, Inc.'s accounts payable and other current liabilities (note 11) has grown at a 27.1% compound annual growth rate (CAGR), from $2.69M to $5.52M.